Dental Care Clinics in Allentown, PA Accepting Medicare
86 Dental Care Clinics found. Showing 81 - 86
 Bradford Young Family & Cosmetic Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 1275 S. Cedar Crest Boulevard, Allentown, PA 18103 Phone: 610-439-1363 Fax: 610-439-1892 |
Jamie M. Yum, D.m.d., P.c. Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 1251 S Cedar Crest Blvd Ste 306, Allentown, PA 18103 Phone: 610-770-0210 Fax: 610-770-0210 |
American Family Dental Care P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1901 Union Blvd, Allentown, PA 18109 Phone: 610-437-5353 Fax: 610-439-5760 |
Allen Valley Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 240 Cetronia Rd, Suite 121 South, Allentown, PA 18104 Phone: 610-841-7929 Fax: 610-841-7931 |
Kenney Dental, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 431 Haines Mill Rd, Allentown, PA 18104 Phone: 610-432-1228 Fax: 610-432-5156 |
Harilal V Dalsania Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1225 Union Blvd, Allentown, PA 18109 Phone: 610-434-8008 |
News Archive
Eleven Biotherapeutics announces pricing of initial public offering of common stock
Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions.
Combination of lapatinib and trastuzumab more effective in treating HER2-positive breast cancer
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
Combination of Herceptin and chemotherapy improves treatment for women with HER2+ breast cancer
Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.
RvE1 protects from inflammation and bone loss in experimental periodontitis
Gum disease is initiated by bacteria populating dental plaque and may eventually result in tissue and tooth loss.
Supreme Court turns down Liberty University's challenge to the health law's employer mandate
The Christian college, located in Virginia, argued that the mandate is unconstitutional, but the high court rejected the petition, marking the second time in two years that it has declined to review the constitutionality of the overhaul's requirements for most large employers regarding health coverage for workers.
› Verified 4 days ago